News

Transformative $70 Million Project Reimagines Calgary Living

Transformative $70 Million Project Reimagines Calgary Living

Transforming Office Spaces into Homes in Calgary

Construction underway for 166 market and affordable housing units.

Dream Office REIT (TSX:D) and Pomerleau Capital have embarked on a groundbreaking $70 million initiative aimed at converting underutilized office space into vibrant residential units. This development, located at 606 4 Street SW, signifies an important shift in Calgary's urban landscape, as it marks the transformation of the former Barclay Centre into desirable living spaces.

A New Model of Urban Living

This project will repurpose approximately 135,000 square feet of office space, bringing 166 new homes to the downtown area. The designs include a mix of studio, one-bedroom, and two-bedroom apartments, catering to diverse housing needs. Importantly, 27% of these units will be designated as affordable housing, addressing critical requirements within the local community.

Meeting Calgary's Housing Demands

The construction's anticipated completion of the first units in 2027 will greatly enhance the livability of Calgary's downtown core. The initiative strategically underscores the importance of urban densification, aligning with municipal policies that call for adaptive reuse and environmental sustainability.

Pioneering Partnership

This collaboration showcases the synergy between Dream and Pomerleau Capital, both entities committed to advancing sustainable urban development. It marks Pomerleau Capital's inaugural venture into the office-to-residential conversion market, emphasizing their strategic approach towards investments that yield long-term community benefits.

Quality Construction by ITC Construction Group

The construction is spearheaded by ITC Construction Group, a key player in residential infrastructure in Western Canada and a subsidiary of Pomerleau. This partnership is indicative of Pomerleau’s robust operational capabilities and its commitment to efficient project delivery.

Voices of Commitment

“Through our collaboration with Pomerleau Capital, this project showcases how innovation in design and development can redefine urban living. By thoughtfully adapting existing spaces, we're creating distinctive homes that contribute to a more sustainable and connected downtown community,” said Jay Jiang, Chief Financial Officer of Dream Office REIT.

Philippe Adam, President and CEO of Pomerleau, added, “We all know that housing needs are significantly growing across Canada. This transformation of unused offices into market and affordable housing offers a practical solution to the housing challenges. We are proud to be part of a partnership that delivers real solutions for communities and look forward to future collaborations with Dream.”

Learn About Dream Office REIT

Dream Office REIT is an unincorporated, open-ended real estate investment trust and a premier office landlord with over 4.0 million square feet of properties managed in downtown Toronto. The REIT's portfolio is carefully curated to include high-quality assets located in one of the world’s foremost office markets, ensuring long-term value and sustainability.

About Pomerleau Capital

Pomerleau Capital serves as the financial arm focused on investments pertaining to infrastructure and building projects. It has successfully structured more than $5 billion in financing for intricate infrastructure undertakings, aspiring to create healthy communities through its investments.

About Pomerleau

Pomerleau ranks as one of Canada’s largest construction firms, generating around $6 billion in annual revenues. With a focus on innovative collaboration and sustainable construction practices, Pomerleau is dedicated to shaping the living environments for future generations. The company employs over 5,000 individuals across more than 200 sites throughout Canada.

Frequently Asked Questions

What is the purpose of the office-to-residential conversion project?

The project aims to transform underused office space into 166 housing units, including affordable options to meet community needs.

When will the first units be completed?

The first residential units are expected to be completed by 2027.

How many units will be designated as affordable housing?

27% of the units will be designated as affordable housing, directly addressing local housing needs.

Who is leading the construction?

ITC Construction Group, a subsidiary of Pomerleau, is responsible for the construction of this project.

What is the significance of this partnership?

This partnership represents a strategic move towards sustainable urban development, demonstrating a commitment to community impact and innovative housing solutions.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Ivonescimab Promises New Hope for Advanced BTC Patients

Updated Category News Views 280

Shifting the Paradigm in Biliary Tract Cancer Treatment Here's the scoop from the bustling world of oncology: the trial of Ivonescimab plus chemotherapy is stirring waves among experts in advanced biliary tract cancer (BTC). Contrary to the usual drowsy mornings with coffee and market pages, this data from Hong Kong wasn't about Wall Street this time. This trial might...

Continue Reading
LexisNexis Debuts AI-Guided Field Clarity at IACP 2026

Updated Category News Views 84

LexisNexis Takes a Serious Step Forward The world of law enforcement reporting just got a shake-up. LexisNexis Coplogic Solutions launched a souped-up version of its Desk Officer Reporting System (DORS) at the IACP 2026 event. They paired DORS with Field Clarity, a newfangled AI-powered assistant that aims to make police reporting slicker and more accurate. You can bet...

Continue Reading
Wenda Pharma's NHWD-870 HCl Shows Promise in Trial

Updated Category News Views 393

Breaking Through in NUT Carcinoma Treatment Imagine battling an aggressive disease with barely any options left, and then something hopeful shows up in the pipeline. That's the story with Zhejiang Wenda Pharma's NHWD-870 HCl, an oral BET inhibitor making waves at the 2026 ESMO Annual Meeting. Facing off against the nasty beast that is NUT carcinoma, this drug didn't just...

Continue Reading
Lilly's Olomorasib: New Data Sparks Hope for G12C NSCLC

Updated Category News Views 186

New Data Unveiling Potential Shifts in NSCLC Treatment Man, if there's one thing the oncology world craved, it's progress against KRAS G12C-mutant non-small cell lung cancer (NSCLC). We're talking about a challenge as tough as a two-dollar steak. But hey, Eli Lilly's (NYSE:LLY) putting some serious cards on the table with olomorasib, and folks at the ESMO 2026 Congress...

Continue Reading
Clarins Dazzles Austin with Skin Longevity Event

Updated Category News Views 21

Clarins Takes Austin by Storm Under the vast Austin sky, something remarkable unfolded as Clarins transformed the scene with a flashy rooftop affair that screamed innovation and elegance. They weren’t just showing off fancy bottles of beauty potion; they were stirring the pot, merging science with a splash of high-end glitz. This wasn’t just another product pitch—it...

Continue Reading
Innovent's IBI3001 Shows Promise in Phase 1 Trials

Updated Category News Views 299

Pioneering Path with IBI3001 at ESMO 2026 Navigating through the crowded landscape of oncology trials, Innovent Biologics recently rolled out some riveting Phase 1 clinical data for their new darling, IBI3001. Top brass from Innovent took to the European Society for Medical Oncology (ESMO) Congress stage to lay bare their findings. Obviously, when you're presenting a...

Continue Reading
Sinclair Faces Labor Lawsuit for Break-time Violations

Updated Category News Views 175

Sinclair Television Caught in Labor Law Storm When you think of flaring tempers and boardroom brawls, you typically don't think of your everyday TV station. But right now, Sinclair Television of California, LLC is in the hot seat, accused of playing fast and loose with wage packets—specifically, allegedly denying meal periods and rest breaks that California labor laws...

Continue Reading
Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study

Updated Category News Views 241

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

Continue Reading
Gildan Activewear Faces Legal Battle Over Alleged Fraud

Updated Category News Views 176

Investor Alert: Gildan's Legal Showdown Alright, here's a twist you didn't see coming—or maybe you did if you've been tracking the ticker tapes like a hawk. Gildan Activewear Inc. (NYSE:GIL) is stuck in the kind of hot water that can scald the bottom line. The Stakes: Racing Towards December 14 Marked on your calendar, December 14, is a date of some significance if...

Continue Reading
DigitalXForce Shakes Up GRC: AI-Infused X-ROC Launch

Updated Category News Views 98

Turning Risk Management on Its Head Well, here's a company not just tinkering around the edges but flipping the script on Governance, Risk, and Compliance (GRC) with their latest rollout: DigitalXForce and its X-ROC. Yeah, it's yet another acronym to juggle, but don't roll your eyes just yet. This AI-driven beast isn't about occasional boardroom reports. No sir, it's a...

Continue Reading

Top 5 Most Recently Viewed Articles

Morgan Stanley Projects Strong Upswing for Consumer Finance

Updated Category News Views 259

Morgan Stanley's Positive Outlook for Consumer Finance Stocks Morgan Stanley has recently made an uplifting adjustment to its outlook on consumer finance stocks, now branding them as "attractive." This decision stems from robust fundamentals and an improved regulatory environment, setting an optimistic tone for the sector. Key Drivers of Change The primary catalysts...

Continue Reading
Significant Board Restructuring at O2Gold Inc. Announced

Updated Category News Views 71

O2Gold Board Announces Key Changes O2Gold Inc. (NEX: OTGO.H), a dedicated mineral exploration company, has recently undergone a significant change in its board structure. The company has announced that Roger Lemaitre has resigned from his position as a director. This decision marks a pivotal moment for O2Gold as it continues to navigate its exploration initiatives....

Continue Reading
Taylor Morrison Launches Holiday Initiative to Support Homeowners

Updated Category News Views 265

Help for Homeowners During the Holidays In a time when financial strain can be prominent, especially during the holidays, Taylor Morrison (NYSE: TMHC) is stepping up to lend a hand. The renowned homebuilder has introduced an initiative designed to support homeowners facing the threat of foreclosure. With the holiday season often heightening financial challenges, the...

Continue Reading
flatexDEGIRO Moves Ahead After Ending BaFin Oversight

Updated Category News Views 188

flatexDEGIRO Ends Special Commissioner Mandate FRANKFURT - flatexDEGIRO AG, a prominent German financial services provider, has officially announced the conclusion of the special commissioner mandate set by the Federal Financial Supervisory Authority (BaFin). This change will take effect on a specified date in the future. The company has made significant strides in...

Continue Reading
Investigating Alvotech's Regulatory Challenges After Stock Drop

Updated Category News Views 125

Alvotech Faces Scrutiny over Manufacturing Issues National shareholder rights firm Hagens Berman is currently analyzing Alvotech (NASDAQ: ALVO) regarding potential misrepresentations in their disclosures tied to manufacturing operations and the regulatory status of their primary biosimilar candidate, AVT05. Impact of FDA's Complete Response Letter The investigation stems...

Continue Reading